ad
Terms related to the query
Term Similarity Weight in brain map N In query
parietal
0.00154855128459637
1.0
10159 In expansion
precuneus
0.002450983087648956
0.9007919213036018
5186 In expansion
hippocampus
0.001378990152341206
0.7215380472389277
4610 In expansion
temporal
0.0018444207100592777
0.6121306787002142
11897 In expansion
cingulate
0.0012074970574721725
0.5335902887604638
9501 In expansion
fa
0.0016751729157782344
0.49946552029324254
1796 In expansion
occipital
0.0006476290823819447
0.28319858595135206
6796 In expansion
medial temporal
0.001753214227683444
0.2566629761876684
2289 In expansion
parahippocampal
0.0007082945034529541
0.2060079834354094
3512 In expansion
white matter
0.0007466484546855904
0.1853189414041064
4236 In expansion
tensor
0.0015697114617043001
0.1829682854490626
1361 In expansion
matter
0.0007026807875623039
0.15563901833744623
6324 In expansion
white
0.00048157274322589174
0.09147881863876585
6774 In expansion
pcc
0.0008864229460843771
0.0864006261725578
1595 In expansion
prefrontal
0.0002647520849666536
0.07963107332178548
10017 In expansion
fusiform
0.00014809407624930153
0.07397303255393398
4278 In expansion
frontal
0.0003423549711013608
0.07287486004001843
11471 In expansion
lobe
0.0017477516674517131
0.07165254698639253
7551 In expansion
memory
0.0011971855747934625
0.06976691976379616
8405 In expansion
thalamus
0.00013062221604527672
0.06440603783519121
4891 In expansion
dementia
0.0075768046412785775
0.0636576562068594
1312 In expansion
left
0.00025584986712808136
0.04069113432347334
12782 In expansion
auditory
5.97538048990409e-05
0.034772238842023684
4009 In expansion
callosum
0.0004048157939007739
0.028778471509505604
895 In expansion
default mode
0.0001905156816296984
0.024143063705016912
2555 In expansion
corpus
0.0003676807351979659
0.022148455228592157
1153 In expansion
visual
4.067381524321483e-05
0.019504073305738435
10448 In expansion
insula
2.713624015154738e-05
0.017181875329068983
7050 In expansion
lingual
0.00018673311038504381
0.014628480995175332
2312 In expansion
tract
0.0004908405535290508
0.014373106999437764
1267 In expansion
default
6.920910979836499e-05
0.014234032318490315
3687 In expansion
anterior
0.00010712542813344188
0.01310317039374963
11200 In expansion
motion
3.112509922632645e-05
0.012358591359690007
9061 In expansion
right
0.0001846564420605284
0.012068449603880638
13076 In expansion
superior
7.727655644748904e-05
0.0109906498067166
9978 In expansion
fasciculus
0.000323335805877914
0.009873702738162545
652 In expansion
lingual gyrus
0.00019019264269403474
0.009697276537622163
1898 In expansion
basal
0.0005197661799217616
0.008804203093786206
3007 In expansion
motor
1.7834149439093287e-05
0.008655153474396568
7928 In expansion
corpus callosum
0.00026205641645452173
0.007925745922974525
740 In expansion
posterior
0.001958330266079216
0.005544511112113341
10413 In expansion
patient
0.003065650400434944
0.0
7859 In expansion
pathological
0.0019625380023972744
0.0
2628 In expansion
mild
0.006879011855697057
0.0
1855 In expansion
mild cognitive impairment
0.005847418839012082
0.0
644 In expansion
metabolic
0.005678730726266481
0.0
2051 In expansion
mci
0.007524969426974574
0.0
538 In expansion
onset
0.0016551463027023744
0.0
6388 In expansion
region
0.001831700334099432
0.0
13358 In expansion
stage
0.0018835985064972764
0.0
4722 In expansion
cognitive
0.003952890988846864
0.0
11288 In expansion
cognitive decline
0.0017900827113831548
0.0
540 In expansion
clinical
0.0021176561868673067
0.0
7059 In expansion
carrier
0.008136080272376108
0.0
503 In expansion
cholesterol
0.001987448576642614
0.0
106 In expansion
decline
0.0021840930923738406
0.0
1831 In expansion
disease
0.02641501720578835
0.0
5087 In expansion
diagnosis
0.0018640283523985233
0.0
4280 In expansion
csf
0.0028107670636767124
0.0
1397 In expansion
alzheimer disease
0.054822357918647174
0.0
1238 In expansion
amnestic
0.002205127213124233
0.0
241 In expansion
amyloid
0.008408402000118106
0.0
245 In expansion
analysis
0.0015923893475364916
0.0
13429 In expansion
alzheimer
0.05798569729856431
0.0
1345 In expansion
ad
1.0
0.0
947 In query
biomarker
0.0031972746583016037
0.0
957 In expansion
atrophy
0.004349016310706648
0.0
1332 In expansion
impairment
0.003409724886678818
0.0
5107 In expansion
late
0.0016242189064119127
0.0
2137 In expansion
elderly
0.0033956082887410736
0.0
790 In expansion
emission
0.0033637493437115346
0.0
1987 In expansion
early
0.005057338724837116
0.0
6240 In expansion
group
0.0029897918088029394
0.0
12268 In expansion
genetic
0.0021184779458020683
0.0
1704 In expansion
Predicted distribution of activations in the literature
Download map
Publications related to the query
Multivariate and univariate neuroimaging biomarkers of Alzheimer's disease
How early can we predict Alzheimer's disease using computational anatomy?
Neuropsychological profile of prodromal Alzheimer's disease (Prd-AD) and their radiological correlates
Structural MRI changes detectable up to ten years before clinical Alzheimer's disease
The Influence of AD Family History and APOE4 on Mesial Temporal Lobe Activation
CSF YKL-40 and pTau181 are related to different cerebral morphometric patterns in early AD
Quantitative magnetization transfer provides information complementary to grey matter atrophy in Alzheimer's disease brains
Evaluation of the screening power of Cognitive Abilities Screening Instrument for probable Alzheimer's disease using voxel-based morphometry
Twelve-Month Metabolic Declines in Probable Alzheimer's Disease and Amnestic Mild Cognitive Impairment Assessed Using an Empirically Pre-Defined Statistical Region-of-Interest: Findings from the Alzheimer's Disease Neuroimaging Initiative
Application of calibrated fMRI in Alzheimer's disease
A spatial covariance 123I-5IA-85380 SPECT study of α4β2 nicotinic receptors in Alzheimer's disease
Volumetric reduction of the corpus callosum in Alzheimer's disease in vivo as assessed with voxel-based morphometry
In vivoSPECT imaging of vesicular acetylcholine transporter using [123I]-IBVM in early Alzheimer's disease
Different patterns of brain activation in normal aging and Alzheimer's disease from cognitional sight: meta analysis using activation likelihood estimation
Resting-State Network Disruption andAPOEGenotype in Alzheimer's Disease: AlaggedFunctional Connectivity Study
A distinct [18F]MPPF PET profile in amnestic mild cognitive impairment compared to mild Alzheimer's disease
Automated detection of brain atrophy patterns based on MRI for the prediction of Alzheimer's disease
Fractional amplitude of low-frequency fluctuations is disrupted in Alzheimer’s disease with depression
Abnormal degree centrality in Alzheimer's disease patients with depression: A resting-state functional magnetic resonance imaging study
Widespread Disruption of Functional Brain Organization in Early-Onset Alzheimer’s Disease
Covariance PET patterns in early Alzheimer's disease and subjects with cognitive impairment but no dementia: utility in group discrimination and correlations with functional performance
Assessment of Functional Characteristics of Amnestic Mild Cognitive Impairment and Alzheimer's Disease Using Various Methods of Resting-State FMRI Analysis
Nonlinear cerebral atrophy patterns across the Alzheimer's disease continuum: impact of APOE4 genotype
Cardiorespiratory Fitness is Associated with Atrophy in Alzheimer’s and Aging Over Two Years
The prediction of rapid conversion to Alzheimer's disease in mild cognitive impairment using regional cerebral blood flow SPECT
CHOLESTEROL-RELATED GENETIC RISK SCORES ARE ASSOCIATED WITH HYPOMETABOLISM IN ALZHEIMER’S-AFFECTED BRAIN REGIONS
Comparison of regional gray matter volume abnormalities in Alzheimer׳s disease and late life depression with hippocampal atrophy using VSRAD analysis: A voxel-based morphometry study
SPM-based count normalization provides excellent discrimination of mild Alzheimer's disease and amnestic mild cognitive impairment from healthy aging
Failure to modulate neural response to increased task demand in mild Alzheimer's disease: fMRI study of visuospatial processing
Resting state FDG-PET functional connectivity as an early biomarker of Alzheimer's disease using conjoint univariate and independent component analyses